The tirzepatide dosing cycle explained: what to expect week by week

What the SURMOUNT-1 trial tells us about the dosing cycle

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed 2,539 adults with obesity over 72 weeks using exactly this structured weekly cycle. Participants who reached and maintained the 15 mg dose lost an average of around 20–21% of their body weight. That figure is the result of a sustained, unbroken cycle, not a single injection or a short course.

The trial design matters here. Dose escalation was fixed in four-week blocks, and that structure was deliberate: it gives the gastrointestinal system time to adapt before the dose rises. People who experienced more nausea at a new dose level generally found it settled within two weeks of that step. The cycle is designed around that biology, not around convenience.

NICE's appraisal of tirzepatide, published in December 2024, drew on this evidence when it recommended the medicine for adults meeting specific BMI and comorbidity criteria. You can read the NICE appraisal of tirzepatide (TA1026) for the full clinical picture behind the recommendation.

Why the four-week step exists, and what happens if you rush it

A question our prescribers hear most weeks: "Can I go up to the next dose sooner if I feel fine?" The short answer is no, and the reason is worth understanding. The four-week minimum between dose increases isn't a bureaucratic rule, it reflects the time tirzepatide takes to reach steady-state blood levels on each dose. Jumping ahead compresses that window and raises the likelihood of side effects like nausea, vomiting or diarrhoea arriving together rather than spread across a gentler adjustment.

The licensed dose schedule for tirzepatide in the UK runs from 2.5 mg through 5, 7.5, 10, 12.5 and 15 mg, as set out in the medicine's Summary of Product Characteristics on the eMC. Each step is a clinical decision. A prescriber reviews whether you're tolerating the current dose well enough to move up, at nume, that happens before every repeat, not as an afterthought.

If side effects are significant at a given level, staying at that dose longer is a legitimate clinical choice. The maintenance dose is whichever dose you tolerate well and that produces the intended effect, it is not automatically 15 mg for everyone. Some people stay at 10 mg or 7.5 mg for months without any loss of benefit. Understanding how tirzepatide works as a dual GIP and GLP-1 receptor agonist helps explain why lower doses still activate both pathways meaningfully.

Practical cycle management: same day, same time, same site rotation

Picking a fixed injection day and sticking to it is the single most practical thing you can do to keep your cycle consistent. Many people choose a day that fits a weekly routine (Sunday evening, Monday morning) rather than the anniversary of the first injection date, which often falls on an inconvenient day over time.

Injection site rotation matters more than most people realise at the start. The abdomen, outer thigh and upper arm are all licensed sites. Using the same spot repeatedly can cause localised reactions that slow absorption. A simple rotation pattern (left abdomen, right abdomen, left thigh, right thigh) prevents that. Store your pen in the fridge at 2–8°C between uses; the exact room-temperature window if you're travelling is stated in the patient information leaflet and varies by pen, so check that rather than relying on a remembered figure.

If you're curious about how the cycle interacts with hormonal changes, our page on how tirzepatide can affect the menstrual cycle covers what's currently known. And for a broader look at how this treatment fits alongside lifestyle changes, the weight-loss treatment overview is a good starting point.

When the cycle gets disrupted: missed doses, illness and dose holds

Life interrupts the best-laid schedules. The missed-dose rule is clear: if fewer than four days have passed since your missed dose, take it and then continue from that new day. If more than four days have passed, skip it entirely and inject on your next originally scheduled day. Never inject two doses to compensate, the safety profile is built around one dose per seven-day window.

Illness that causes persistent vomiting or diarrhoea can affect hydration, and severe dehydration on GLP-1 medicines carries a small risk of kidney strain. If you're genuinely unwell, it is worth contacting your prescriber rather than pushing through. At nume, aftercare support is available seven days a week precisely because cycle questions don't always arise on a Monday morning.

People occasionally ask about pausing the cycle entirely, whether for a planned procedure or a period of illness. Surgery is one context where your prescriber needs to know well in advance, anaesthetists want to factor in gastric emptying when planning sedation. Discuss any planned hold with your clinical team; restarting protocol varies depending on how long the pause was.

For a full comparison of tirzepatide with other weight-management options, the Mounjaro or tirzepatide page clarifies the UK brand relationship, and the Mounjaro overview covers the broader treatment picture. If cost is a consideration, the cost context page sets out what legitimate UK pricing actually looks like. Patients starting at the initial dose can also find detailed guidance on tirzepatide l dosing on our dedicated page for that strength.

If you'd like a prescriber to review whether this treatment and its dosing schedule are right for you, check your eligibility with a free consultation.